Life Science Leader Blogs

  1. The Drug Pricing Dilemma, Pfizer, And President Trump
    7/13/2018

    An op-ed regarding Pfizer’s drug-pricing actions, President Trump, and the potential impact on the biopharmaceutical industry’s image.

  2. At The End Of The Day — And Other Phrases That Could Be Used Less
    7/9/2018

    A review of buzzwords and phrases that should be used less in the world of business.

  3. Did BIO 2018 Do More Than Make History In Boston?
    6/14/2018

    BIO 2018 does more than make business meeting history, but facilitates personal connections that can lead toward doing better business.

  4. BIO 2018 — A View Through The Eyes Of An Aspiring Biomedical Engineer
    6/12/2018

    Miriam Massaad, a biomedical engineering student at Boston University, shares her experiences as a first-time attendee at the 2018 BIO International Convention and Conference in Boston.

  5. What Is MassBio Doing To Promote Greater Diversity And Inclusion?
    6/12/2018

    Robert Coughlin, president and CEO of MassBio, discusses his organization’s approach to diversity and inclusion.

  6. Research Into The State Of Innovation In Highly Prevalent Chronic Diseases
    6/11/2018

    Dave Thomas, managing director for industry research and analysis at the Biotechnology Innovation Organization (BIO), discusses chronic disease research and other industry trends.

  7. The Scientist Mentoring And Diversity Program — An Inside View From A Current Scholar
    6/11/2018

    Shaness Grenald, Ph.D., a postdoctoral fellow in the department of anesthesiology and critical care medicine at Johns Hopkins University, discusses the Scientist Mentoring and Diversity Program (SMDP) at the 2018 BIO Buzz Center in Boston. 

  8. Are You Ready For BIO 2018 In Boston?
    5/22/2018

    Tips to help you get ready for the 2018 BIO International Convention in Boston, June 4 - 7.

  9. Is The Open Office Concept An Idea That Should Have Been Killed?
    5/18/2018

    Rob Wright discusses the open office concept, and if it is an idea that should be killed.

  10. A Testament To Biopharma’s Transparent Leaders: And A Previously Unpublished Regeneron Article Sidebar
    5/18/2018

    Rob Wright discusses the unusual genesis of the Regeneron Genetics Center (RGC).